SMARCB1 and atypical teratoid rhabdoid tumor: With the development of gene sequencing technology, an increasing number of studies have confirmed that the tumor suppressor gene INI1/SMARCB1, which is ubiquitously expressed in normal tissue, is completely lost in MRTs and atypical teratoid/rhabdoid tumors (ATRTs).